Delisting riskPopularity #4,543
MDxHealth (MDXH)
Molecular prostate-cancer tests for testing and treatment decisions.
$0.5960
vs last close−0.00 (−0.65%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 32.30% | 16.59M ADS | |
|---|---|---|---|
| 26 holders · as of Jun 30, 2026 | |||
| Insiders | 6.22% | 3.19M ADS | |
| 2 holders · as of Apr 13, 2026 | |||
| Strategic holders | 12.54% | 6.44M ADS | |
| 1 holder · as of Jan 16, 2026 | |||
| Other | 48.94% | 25.14M ADS | |
| remainder | |||
51.36M ADS (1 ADS = 3 ordinary shares) as of Sep 10, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
The share count is from the company's Dec 2021 annual report; nothing newer is on file here.
13F, as of Jun 30, 2026
26 holders · 16.59M shares · 5 new positions · 12 increased · 5 reduced · 30 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Bleichroeder LP | 7.38M | 14.36% | 0 | Aug 13, 2026 |
| MVM Partners, LLC | 4.70M | 9.15% | 0 | Aug 14, 2026 |
| Perkins Capital Management Inc | 1.41M | 2.75% | −64.6K | Jul 24, 2026 |
| Citadel Advisors LLC | 509.7K | 0.99% | +450.0K | Sep 2, 2026 |
| Jane Street Group, LLC | 503.2K | 0.98% | +503.2K | Aug 14, 2026 |
| Gsa Capital Partners LLP | 482.0K | 0.94% | +470.9K | Aug 6, 2026 |
| Renaissance Technologies LLC | 325.1K | 0.63% | +20.4K | Aug 13, 2026 |
| Millennium Management LLC | 228.5K | 0.44% | −316.2K | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Bleichroeder LP | 33.20% | 31.65M | 13D | Aug 14, 2026 |
| Genomic Health, Inc. | 12.00% | 6.44M | 13G | Jan 16, 2026 |
| Laurence W. Lytton | 11.00% | 2.89M | 13G | Oct 4, 2024 |
| AWM Investment Company, Inc. | 10.30% | 4.88M | 13G | Feb 7, 2025 |
| Exact Sciences Corporationincl. Genomic Health, Inc. | 7.10% | 3.44M | 13G | Oct 4, 2024 |
| Lytton Laurence W | 6.40% | 3.16M | 13G | Nov 14, 2025 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 13, 2026 | MVM Partners, LLCdirector | Purchase | 2,202,643 | $0.4540 | 6,903,100 |
House and Senate disclosures
Not reported.